abstract |
The present invention relates to a pharmaceutical combination preparation comprising ezetimibe and rosuvastatin. The pharmaceutical combination preparation has a water activity of 0.40 or less. The pharmaceutical combination preparation can further comprise one or more ingredients selected the group consisting of amlodipine, losartan, and combinations thereof, and the ezetimibe is present in a physically separated state from rosuvastatin, amlodipine, and losartan, respectively. |